Literature DB >> 33348085

Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5.

Glenn J Jaffe1, Usha Chakravarthy2, K Bailey Freund3, Robyn H Guymer4, Frank G Holz5, Sandra Liakopoulos6, Jordi M Monés7, Philip J Rosenfeld8, Srinivas R Sadda9, David Sarraf10, Steffen Schmitz-Valckenberg11, Richard F Spaide3, Giovanni Staurenghi12, Adnan Tufail13, Christine A Curcio14.   

Abstract

PURPOSE: To provide an image-based description of retinal features associated with risk for development of geographic atrophy (GA) in eyes with age-related macular degeneration (AMD), as visualized with multimodal imaging anchored by structural OCT.
DESIGN: Consensus meeting. PARTICIPANTS: International group that included those with expertise in imaging and AMD basic science and histology, and those with Reading Center experience in AMD clinical trials.
METHODS: As part of the Classification of Atrophy Meeting program, an international group of experts analyzed and discussed retinal multimodal imaging features in eyes with AMD associated with GA, risk of progression to GA, or both. Attendees undertook premeeting grading exercises that were reviewed during the meeting sessions. Meeting presentations illustrated established and investigational multimodal imaging features and associated histologic features. Each of these different features were then discussed openly by the entire group to arrive at consensus definitions. These definitions were applied to 40 additional images that were graded independently by attendees to refine the consensus definitions and descriptions further.
RESULTS: Consensus was reached on images with descriptors for 12 features. These features included components of outer retinal atrophy (e.g., ellipsoid zone disruption), components of complete retinal pigment epithelium (RPE) and outer retinal atrophy (e.g., RPE perturbation with associated hypotransmission or hypertransmission), features frequently seen in eyes with atrophy (e.g., refractile drusen), and features conferring risk for atrophy development (e.g., hyperreflective foci, drusen, and subretinal drusenoid deposits).
CONCLUSIONS: An international consensus on terms and descriptions was reached on multimodal imaging features associated GA and with risk for GA progression in eyes with AMD. We believe this information will be useful to clinicians who manage patients with AMD, researchers who study AMD disease interventions and pathogenesis, and those who design clinical trials for therapies targeting earlier AMD stages than GA expansion.
Copyright © 2020 American Academy of Ophthalmology. All rights reserved.

Entities:  

Keywords:  Age-related macular degeneration; Atrophy; Multimodal imaging; OCT

Mesh:

Year:  2020        PMID: 33348085     DOI: 10.1016/j.oret.2020.12.009

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN: 2468-6530


  21 in total

1.  [Are "pachychoroid spectrum disorders" a topic for CME?]

Authors:  H Helbig; F Grehn; W A Lagrèze; U Pleyer; B Seitz
Journal:  Ophthalmologe       Date:  2021-08-05       Impact factor: 1.059

2.  Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections.

Authors:  Takayuki Baba; Gen Miura; Tomoaki Tatsumi; Madoka Sakurai; Shuichi Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2021-03-21       Impact factor: 2.447

Review 3.  Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Authors:  Hannah J Yu; Charles C Wykoff
Journal:  BioDrugs       Date:  2021-04-24       Impact factor: 5.807

4.  [Uniform classification of the pachychoroid spectrum disorders].

Authors:  Alaa Din Abdin; Shady Suffo; Fabian N Fries; Hakan Kaymak; Berthold Seitz
Journal:  Ophthalmologe       Date:  2021-04-26       Impact factor: 1.059

5.  Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study.

Authors:  Tamaki Tamashiro; Koji Tanaka; Kanako Itagaki; Makiko Nakayama; Ichiro Maruko; Sorako Wakugawa; Nobuhiro Terao; Hajime Onoe; Yu Wakatsuki; Masashi Ogasawara; Yukinori Sugano; Akiko Yamamoto; Keiko Kataoka; Takahiko Izumi; Moeko Kawai; Ryusaburo Mori; Tetsuju Sekiryu; Annabelle A Okada; Tomohiro Iida; Hideki Koizumi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-16       Impact factor: 3.117

6.  Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy.

Authors:  Seongyong Jeong; Wonki Kang; Donghyoun Noh; Jano van Hemert; Min Sagong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-13       Impact factor: 3.117

7.  Impact of the Aging Lens and Posterior Capsular Opacification on Quantitative Autofluorescence Imaging in Age-Related Macular Degeneration.

Authors:  Andreas Berlin; Mark E Clark; Thomas A Swain; Nathan A Fischer; Gerald McGwin; Kenneth R Sloan; Cynthia Owsley; Christine A Curcio
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

8.  [Acute unilateral loss of vision after intravitreal injection of a VEGF inhibitor].

Authors:  N Kaupke; N Stübiger; S Dulz; M S Spitzer; M Casagrande
Journal:  Ophthalmologe       Date:  2021-02-25       Impact factor: 1.059

9.  Spectral and lifetime resolution of fundus autofluorescence in advanced age-related macular degeneration revealing different signal sources.

Authors:  Rowena Schultz; Somar Hasan; Christine A Curcio; Roland T Smith; Daniel Meller; Martin Hammer
Journal:  Acta Ophthalmol       Date:  2021-07-13       Impact factor: 3.988

10.  [Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration].

Authors:  Marius Book; M Ziegler; K Rothaus; H Faatz; M Gutfleisch; G Spital; A Lommatzsch; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2021-08-05       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.